β-Arrestins turn off G protein-mediated signals and initiate distinct G protein-independent signaling pathways. We previously demonstrated that angiotensin AT 1 receptorbound β-arrestin 1 is cleaved after Phe 388 upon angiotensin II stimulation. The mechanism and signaling pathway of angiotensin II-induced β-arrestin cleavage remain largely unknown. Here, we show that protein Tyr phosphatase activity is involved in the regulation of β-arrestin 1 cleavage. Tagging of green fluorescent protein (GFP) either to the N-terminus or C-terminus of β-arrestin 1 induced conformational changes and the cleavage of β-arrestin 1 without angiotensin AT 1 receptor activation. Orthovanadate and molybdate, inhibitors of protein Tyr phosphatase, attenuated the cleavage of C-terminal GFP-tagged β-arrestin 1 áå=îáíêç. The inhibitory effects of okadaic acid and pyrophosphate, which are inhibitors of protein Ser/Thr phosphatase, were less than those of protein Tyr phosphatase inhibitors. Cell-permeable pervanadate inhibited angiotensin II-induced cleavage of β-arrestin 1 in COS-1 cells. Our findings suggest that Tyr phosphorylation signaling is involved in the regulation of angiotensin II-induced β-arrestin cleavage.
INTRODUCTION
The angiotensin AT 1 receptor belongs to the G protein-coupled receptor family and transduces diverse signals in G proteinand β-arrestin-dependent pathways (Oro et al., 2007) . Upon angiotensin II binding to the angiotensin AT 1 receptor, a conformational change in the receptor modulates G protein, Gq, and activates phospholipase C β for IP 3 and Ca
2+
-mediated vasoconstriction (Oro et al., 2007) . β-Arrestin 1 and 2, ubiquitously expressed in mammalian tissues, are recruited from the cytoplasm to the activated angiotensin AT 1 receptor for clathrinmediated endocytosis (Krupnick et al., 1997) . In addition to the role in desensitization and endocytosis, β-arrestins form scaffolds for a number of signaling molecules in mitogen-activated protein kinase (MAPK) cascades and non-receptor Tyr kinases for G protein-independent signals (Lefkowitz and Shenoy, 2005) . The β-arrestin 1 and 2 are comprised of N-and Cdomains of equal size (Han et al., 2001) , with the N-domain serving as a phosphate sensor recognizing the phosphorylated G protein-coupled receptor (Nobles et al., 2007) and the Cdomain acting as adaptor binding sites for clathrin and AP-2 (Lin et al., 1997) . Previous studies have shown that there are distinct inactive and active conformations in β-arrestin. In the inactive state, the polar core between the N-and C-domain of β-arrestin 1 is kept intact with the C-terminus buried in the structure (Han et al., 2001) . However, once β-arrestin 1 is bound to the phosphorylated receptor, a conformational change in β-arrestin occurs and extrudes its C-terminal region towards the outside, thus enabling the binding of clathrin and AP-2 for clathrin-mediated endocytosis (Lefkowitz and Shenoy, 2005) . β-Arrestin 1 and 2 have distinct active conformations when bound to the activated receptor (Nobles et al., 2007; Xiao et al., 2004) .
In a previous study, we showed that a fraction of β-arrestin 1 bound to the angiotensin AT 1 receptor is cleaved upon receptor activation and it requires stable interaction between the angiotensin AT 1 receptor and β-arrestin (Lee et al., 2008) . Angiotensin II and inverse agonist EXP3174 induced cleavage at distinct sites on β-arrestin 1; after Phe 388 upon angiotensin II treatment and after Pro 276 upon EXP3174 treatment, respectively. These results suggested ligand-induced selectivity in β-arrestin-mediated signaling. With distinct cleavage sites of β-arrestin 1 and 2 by angiotensin II, our data also demonstrated that the receptor-bound active conformations of β-arrestin 1 and 2 are different. The biological significance and the signaling pathway of ligand-induced β-arrestin cleavage, however, are largely unknown.
In this study, we sought to elucidate the regulatory mechanism of angiotensin II-mediated β-arrestin 1 cleavage in COS-1 cells expressing the angiotensin AT 1 receptor. Since protein kinase activation has been implicated in the activation of prote-ases downstream of angiotensin AT 1 receptor (Eguchi et al., 2001) , we hypothesized that β-arrestin proteolysis is regulated by cellular protein kinases or phosphatases. We used inhibitors of protein Tyr or Ser/Thr phosphatase to investigate the effect on β-arrestin proteolysis. Here, we show that cell-permeable pervanadate inhibits angiotensin II-induced cleavage of β-arrestin 1 in COS-1 cells. Our finding suggests that protein Tyr phosphatase activity is involved in the regulation of G proteincoupled receptor-engaged β-arrestin proteolysis.
MATERIALS AND METHODS

Materials
Angiotensin II was purchased from Bachem (USA). Lipofectamine 2000 was purchased from Invitrogen (USA). Monoclonal antibodies to myc and β-arrestin 2 (H-9) were purchased from Santa Cruz Biotechnology, Inc. (USA). Since the anti-β-arrestin 2 antibody (H-9) recognized both β-arrestin 1 and 2 in our previous studies (Lee et al., 2007; 2008) , we used this antibody for the detection of transfected β-arrestin 1 in this study. Monoclonal antibody to GFP was purchased from Clontech (USA). Horseradish peroxidase (HRP)-labeled goat anti-mouse secondary antibody was purchased from Upstate (USA). COS-1 cells were purchased from American Type Culture Collection (USA). Western blot stripping buffer was purchased from Pierce (USA). All other reagents, unless stated otherwise, were from Sigma (USA).
Construction of myc-β-arrestin 1, GFP-β-arrestin 1, and β-arrestin 1-GFP plasmids Three fusion constructs with myc or GFP-tagged β-arrestin 1 were generated by polymerase chain reaction by the following primers using éÑì DNA polymerase. For Myc-β-arrestin 1, the forward primer was 5′-AACCGGATCCGATGGGCGACAAA-GGGAC-3′ (_~ãHI site underlined, and the N-terminus of β-arrestin 1 in boldface type), and the reverse primer was 5′-AACCCTCGAGCTATCTGTCGTTGAGCCGCGGAG-3′ (uÜçI site underlined, the C-terminus of β-arrestin 1 in boldface type). For the N-terminal GFP-tagged GFP-β-Arrestin 1, the cDNA for cloning was subcloned into pEGFP-C1 vector (Clontech). The forward primer was 5′-AACCCTCGAGCCATGGGCGACAAA-GGGAC-3′ (uÜçI site underlined, and the N-terminus of β-arrestin 1 in boldface type), and the reverse primer was 5′-AACCGGATCCCTATCTGTCGTTGAGCCGCG-3′ (_~ãHI site underlined, and the C-terminus of β-arrestin 1 in boldface type). The C-terminal GFP tagged β-Arrestin 1-GFP was generated using pEGFP-N3 vector. The forward primer was 5′-CCCC-CTCGAGTCTACCATGGGCGACAAAGGGAC-3′ (XhoI site underlined, and the N-terminus of β-arrestin 1 in boldface type), and the reverse primer was 5′-AACCGGATCCTCTGTCGT-TGAGCCCGCGGAGAGC-3′ (_~ãHI site underlined, and the C-terminus of β-arrestin 1 in boldface type). Accuracy of the fusion constructs in the expression vector was confirmed by DNA sequence analysis.
Cell culture and expression of the angiotensin AT 1 receptor and β-arrestin 1 The synthetic rat angiotensin AT 1 receptor gene, cloned in the shuttle expression vector pMT3, was used for expression. To express the angiotensin AT 1 receptor and β-arrestin 1, 60-65% confluent COS-1 cells were grown in 6-well plates and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. The cells were transfected with 2 μg of purified angiotensin AT 1 receptor and β-arrestin 1 cDNA using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions.
Western blotting
The following protocol was used for the detection of cleaved β-arrestin fragment. Transfected cells, cultured for 48 h, were treated with 1 μM angiotensin II or mock. Cells were washed with cold PBS and centrifuged at 13,000 rpm for 1 min at 4°C. Cell pellets were lysed in 100 μl of lysis buffer (25 mM HEPES, pH 7.2, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM PMSF, 10 mM sodium pyrophosphate, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 10% glycerol) for 60 min. The Sigma protease inhibitor mixture (P2714) was added to the lysis buffer. Cell lysates were centrifuged at 13,000 rpm for 10 min at 4°C to remove cell debris. Protein concentration was measured using Bradford assay kit (Bio-Rad). The 20 μg of total protein was dissolved in Laemmli's sample buffer, boiled for 5 min at 95°C, and separated by SDS-PAGE with a 10% separation gel. Following electrophoresis, the proteins were transferred to nitrocellulose membranes and then blocked for 1 h at room temperature in 5% non-fat dry milk and 0.1% Tween-20 in PBS, pH 7.4. Incubation with primary antibody was carried out overnight at 4°C. Following washes with PBS, incubation with HRP-labeled secondary antibody was carried out for 1 h at room temperature. The detection was made with enhanced chemiluminescence (GE Healthcare) and the films were scanned for densitometry analysis using Fuji Multiguage V3.0 Software (Fuji Film). For the data shown in Fig. 3 , the experimental procedures described above were followed except that the lysis buffer was prepared without any phosphatase inhibitors. Each phosphatase inhibitor component was added separately into lysis buffer to a final concentration of 25 mM β-glycerophosphate, 10 mM sodium fluoride, 10 mM sodium pyrophosphate, 1 mM okadaic acid, 1 mM sodium orthovanadate, or 1 mM sodium molybdate. Data analysis was performed using GraphPad Prism 4 (GraphPad Software). Student's í-test was used for statistical analysis in Figs. 1 and 3 .
Pervanadate preparation and treatment Pervanadate was prepared using a 2 min incubation of 100 mM sodium orthovanadate and hydrogen peroxide in distilled water, followed by dilution to the appropriate concentration in serumfree DMEM. The solutions were used within 1 h of preparation.
RESULTS
β-Arrestin cleavage in COS-1 cells In our previous pull-down assays, we demonstrated that β-arrestin 1 bound to the angiotensin AT 1 receptor is cleaved upon angiotensin II stimulation in rat aortic smooth muscle (A7r5) cells and COS-1 cells (Lee et al., 2008) . To detect the cleavage of β-arrestin 1 without immunoprecipitation, samples were blotted with anti-β-arrestin antibody (H-9) after cell lysis, SDS-PAGE, and transfer to nitrocellulose membrane. As shown in Fig. 1A , the cleaved β-arrestin 1 was detected and band intensity for the cleaved fragment was increased upon angiotensin II treatment (1.34 ± 0.13 fold, P < 0.05).
To confirm the cleavage event, the N-terminal myc-tagged β-arrestin 1 was constructed and assayed for the cleavage with anti-myc or anti-β-arrestin antibody. Surprisingly, substantial amount of cleaved myc-β-arrestin 1 fusion protein was found in the absence of angiotensin AT 1 receptor in transiently transfected COS-1 cells. We speculate that the myc fusion to the Nterminus of β-arrestin 1 induces a conformational instability in β-arrestin. The cleavage of myc-β-arrestin 1 was enhanced following angiotensin II treatment (1.26 ± 0.11 fold, P < 0.05, blot-
